Trifluoroacetic acid → HCID 22119938, compound
Reaction equation
[C:1]([CH:4]([CH2:12][C:13]1[C:17]2[CH:18]=[C:19]([N:22]3[C:27](=[O:28])[CH:26]=[C:25]([C:29]([F:32])([F:31])[F:30])[N:24]([CH3:33])[C:23]3=[O:34])[CH:20]=[CH:21][C:16]=2[S:15][N:14]=1)C(OC(C)(C)C)=O)(=[O:3])[CH3:2].FC(F)(F)C(O)=O>C(Cl)Cl>[CH3:33][N:24]1[C:25]([C:29]([F:30])([F:31])[F:32])=[CH:26][C:27](=[O:28])[N:22]([C:19]2[CH:20]=[CH:21][C:16]3[S:15][N:14]=[C:13]([CH2:12][CH2:4][C:1](=[O:3])[CH3:2])[C:17]=3[CH:18]=2)[C:23]1=[O:34]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of tert-butyl α-acetyl-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-1,2-benzisothiazole-3-propionate (0.700 g) and trifluoroacetic acid (10.0 mL) in methylene chloride is stirred overnight at room temperature, concentrated in vacuo, and diluted with methylene chloride and saturated sodium hydrogen carbonate solution. The phases are separated. The organic phase is dried over anhydrous magnesium sulfate and concentrated in vacuo to give 1-methyl-3-[3-(3-oxobutyl)-1,2-benzisothiazol-5-yl]-6-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione as a white solid (0.310 g, mp 198-199° C.). The aqueous phase is acidified with concentrated hydrochloric acid, stirred for several minutes, and filtered to obtain a solid. The solid is washed with water and air-dried to give α-acetyl-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-1,2-benzisothiazole-3-propionic acid as a white solid, mp 191-193° C.
Workup
- concentrationconcentrated in vacuo
- additiondiluted with methylene chloride and saturated sodium hydrogen carbonate solution
- customThe phases are separated
- dry with materialThe organic phase is dried over anhydrous magnesium sulfate
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-7c01316c5fbc4fba915ef2c6ea62ee23
- Source dataset
- uspto-grants-2000_12
- Patent number
- US06156700
Reaction notes
Loading…